Press release
Esperovax Receives Subcontract for Thermostable Oral Vaccine Platform Development
Thermostable Vaccines Market
Vaccines are among the most effective tools in modern medicine, preventing millions of deaths annually. However, one of the persistent challenges in global immunization programs is the cold chain requirement - the need to store and transport vaccines at specific low temperatures to maintain efficacy. This poses significant hurdles in low- and middle-income countries (LMICs), rural areas, and during emergencies where refrigeration infrastructure is limited.
Thermostable vaccines - designed to remain effective at higher temperatures without strict cold chain requirements - are emerging as a game-changer in vaccine delivery. By reducing dependency on cold storage, these vaccines can lower costs, expand coverage, and improve resilience during pandemics. Over the next decade, the thermostable vaccines market is expected to grow rapidly as healthcare systems prioritize accessibility and global health equity.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72652
Market Overview
• The global thermostable vaccines market size in 2024 is estimated at USD 2.9 billion.
• It is projected to reach USD 8.1 billion by 2034, growing at a CAGR of 10.8 % during the forecast period.
• Growth is being driven by increasing immunization campaigns, pandemic preparedness strategies, and investments in vaccine R&D.
Key Market Drivers:
• Rising demand for vaccines in low-resource settings with limited cold chain facilities.
• Increasing global initiatives for universal immunization.
• Strong R&D focus on thermostable formulations for COVID-19, polio, and influenza.
• Cost savings and logistical efficiency in vaccine distribution.
Key Challenges:
• Technical barriers in achieving long-term stability for complex biologics.
• Stringent regulatory requirements for approval.
• Competition from established cold-chain vaccine distribution systems.
Leading Players:
GlaxoSmithKline plc, Merck & Co., Sanofi, Pfizer Inc., Bharat Biotech, Serum Institute of India, CureVac, and Moderna.
Segmentation Analysis
The thermostable vaccines market can be segmented as follows:
By Vaccine Type
• Live Attenuated Vaccines
• Inactivated Vaccines
• Subunit & Recombinant Vaccines
• mRNA Vaccines
• Others
By Disease Indication
• COVID-19
• Influenza
• Polio
• Hepatitis
• Rotavirus
• Others
By Distribution Channel
• Hospitals & Clinics
• Government Immunization Programs
• NGOs & Global Health Organizations
• Retail & Online Pharmacies
By End-Use
• Adults
• Pediatrics
• Elderly Population
Summary:
Live attenuated and inactivated vaccines dominate the current market, but mRNA thermostable vaccines are gaining momentum due to pandemic preparedness and advances in lipid nanoparticle technology. Government immunization programs account for the largest share of distribution, supported by WHO, UNICEF, and Gavi initiatives.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72652/thermostable-vaccines-market
Regional Analysis
North America
• Strong R&D base with companies like Pfizer, Moderna, and Merck driving innovation.
• Increasing focus on pandemic preparedness and next-gen vaccine platforms.
Europe
• Active adoption of thermostable formulations in immunization programs.
• EU-funded research projects supporting cold chain-independent vaccines.
Asia-Pacific (APAC)
• Expected to record the fastest CAGR (~12.4 %) from 2024-2034.
• India and China lead with manufacturing hubs such as Serum Institute and Bharat Biotech.
• Expanding government immunization programs and rising healthcare access fuel demand.
Middle East & Africa (MEA)
• Strong need for thermostable vaccines due to cold chain challenges in rural areas.
• Increasing adoption via UNICEF and Gavi-funded campaigns.
Latin America
• Brazil and Mexico dominate, with growing focus on local vaccine production and distribution.
Regional Summary:
While North America and Europe lead in innovation, Asia-Pacific and MEA will be critical markets due to their large populations, rising immunization needs, and infrastructure limitations.
Market Dynamics
Growth Drivers
1. Elimination of cold chain dependency, lowering logistical barriers.
2. Expansion of global vaccination campaigns in LMICs.
3. Rising investments in thermostable COVID-19 and influenza vaccines.
4. Increasing partnerships between global health organizations and vaccine manufacturers.
Key Challenges
• Achieving stability for sensitive biologics like mRNA and protein subunits.
• High R&D costs for novel thermostable formulations.
• Market dominance of existing cold-chain-dependent vaccines.
Latest Trends
• Development of lyophilized (freeze-dried) vaccines stable at ambient temperatures.
• Progress in spray-dried formulations for oral and nasal vaccines.
• Integration of AI and computational biology for stability optimization.
• Growing adoption of public-private partnerships to accelerate access in emerging markets.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72652
Competitor Analysis
Major Players:
• GlaxoSmithKline plc
• Merck & Co.
• Sanofi
• Pfizer Inc.
• Bharat Biotech
• Serum Institute of India
• CureVac
• Moderna
• Johnson & Johnson
• CSL Limited
Competitive Summary:
The market is characterized by strong global players like Pfizer, Sanofi, and Merck, alongside emerging innovators such as Bharat Biotech and Serum Institute of India, which focus on cost-effective mass production. Partnerships with WHO, Gavi, and UNICEF are critical for scaling access in developing nations.
Conclusion
The thermostable vaccines market is projected to expand from USD 2.9 billion in 2024 to USD 8.1 billion by 2034, at a CAGR of 10.8 %.
This report is also available in the following languages : Japanese (耐熱性ワクチン市場), Korean (열안정성 백신 시장), Chinese (耐热疫苗市场), French (Marché des vaccins thermostables), German (Markt für thermostabile Impfstoffe), and Italian (Mercato dei vaccini termostabili), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72652
Our More Reports:
Nutraceutical Product Testing Market
https://exactitudeconsultancy.com/reports/72396/nutraceutical-product-testing-market
Meditation Market
https://exactitudeconsultancy.com/reports/72394/meditation-market
Peptide Receptor Radionuclide Therapy Market
https://exactitudeconsultancy.com/reports/72392/peptide-receptor-radionuclide-therapy-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Esperovax Receives Subcontract for Thermostable Oral Vaccine Platform Development here
News-ID: 4202189 • Views: …
More Releases from Exactitude Consultancy
A combination of anti-aging drug increases the lifetime of mice by 30% and gives …
The global Anti-Aging Drugs Market is entering a dynamic growth phase, fueled by advances in regenerative medicine, biotechnology, and preventive healthcare. As populations age worldwide, the demand for therapies that extend not just lifespan but healthspan-the number of years lived in good health-is accelerating. Anti-aging drugs aim to target biological mechanisms of aging, delay age-related diseases, and improve overall quality of life. With growing investment in longevity research, breakthroughs in…
FDA decision on relacorilant for Cushing's expected by year's end
Introduction
Cushing's syndrome is a rare but serious endocrine disorder caused by prolonged exposure to high cortisol levels. It can occur due to long-term use of corticosteroid medications or because of tumors that produce excess adrenocorticotropic hormone (ACTH). Symptoms such as weight gain, hypertension, diabetes, osteoporosis, and psychological changes significantly impact patients' quality of life.
Though rare, Cushing's syndrome has become an important therapeutic focus in endocrinology because of the severe health…
RNA Extraction and Purification Market to Reach USD 5.4 Billion by 2034
The global RNA Extraction and RNA Purification Market is a critical segment of the molecular biology and life sciences ecosystem, enabling breakthroughs in genomics, diagnostics, drug development, and therapeutic research. RNA purification is essential for applications such as next-generation sequencing (NGS), polymerase chain reaction (PCR), transcriptome analysis, biomarker discovery, and vaccine development. The COVID-19 pandemic underscored the importance of robust RNA extraction technologies for viral detection, while ongoing advances in…
Advances in the Study of Macular Degeneration Addressing the Rising Global Burde …
Introduction
Macular degeneration, particularly age-related macular degeneration (AMD), is one of the leading causes of irreversible vision loss among adults over 50. It affects the macula - the central portion of the retina responsible for sharp, detailed vision. With aging populations and lifestyle-related risk factors on the rise, the global prevalence of AMD is growing at an alarming rate.
While treatments such as anti-VEGF (vascular endothelial growth factor) injections have transformed disease…
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
